Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Amyloidosis × carfilzomib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 154 Recurrence 30 Neoplasms, Plasma Cell 16 Lymphoma 11 Neoplasms 6 Waldenstrom Macroglobulinemia 5 Lymphoma, Mantle-Cell 5 Smoldering Multiple Myeloma 4 Lymphoma, Non-Hodgkin 4 Leukemia 4 Small Cell Lung Carcinoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 3 Hodgkin Disease 3 Hematologic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Ovarian Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Disease 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Sezary Syndrome 1 Salivary Gland Adenoma, Pleomorphic 1 Renal Insufficiency 1

Interventions

Dexamethasone 16 Melphalan 9 Calcium Dobesilate 8 Bortezomib 7 Cyclophosphamide 6 Lenalidomide 5 miridesap 3 venetoclax 2 pomalidomide 2 ixazomib 2 belantamab mafodotin 2 Thalidomide 2 Doxycycline 2 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 carfilzomib 1 birtamimab 1 auricularum 1 Vinorelbine 1 Technetium Tc 99m Pyrophosphate 1 Technetium 1 Tacrolimus 1 Surveys and Questionnaires 1 Pharmaceutical Preparations 1 Lisaftoclax 1 Interleukin-2 1 Hyaluronoglucosaminidase 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02545907 2021-04-15

CATALYST

University College, London

Phase 1/2 Completed

10 enrolled 14 charts

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡